2530-54-3

Basic information

• Product Name: O,O,O,O-tetraethylbenzylidenediphosphonate
• Synonyms: O,O,O,O-tetraethylbenzylidenediphosphonate
• CAS NO: 2530-54-3
• Molecular Weight: 364.315
• Mol File: 2530-54-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: O,O,O,O-tetraethylbenzylidenediphosphonate(CAS DataBase Reference)
• NIST Chemistry Reference: O,O,O,O-tetraethylbenzylidenediphosphonate(2530-54-3)
• EPA Substance Registry System: O,O,O,O-tetraethylbenzylidenediphosphonate(2530-54-3)

Safety Data

• Hazardous Substances Data: 2530-54-3(Hazardous Substances Data)

Upstream product

• 98-87-3 benzylidene dichloride 
• 122-52-1 triethyl phosphite 
• 884-90-2 benzyl diethyl phosphate 
• 814-49-3 diethyl chlorophosphate 
• 1080-32-6 O,O-diethyl benzylphosphonate 
• 1663-55-4 diethyl [hydroxy(phenyl)methyl]phosphonate 
• 762-04-9 phosphonic acid diethyl ester 

Relevant articles and documents

Studies on organophosphorus compounds 68. A new and facile synthetic approach to alkylidenebisphosphonates

Condensation of aldehydes with diethyl phosphite followed by sulfonylation of the α-hydroxy group formed with methanesulfonyl chloride and subsequent substitution by another molecule of diethylphosphite provides corresponding alkylidenebisphosphonates in one-pot procedure with good yield.

Modified Colorants and Inkjet Ink Compositions Comprising Modified Colorants

The present invention relates to a modified colorant comprising a colorant having attached at least one organic group. Various embodiments of the organic group are disclosed. For each of these embodiments, preferably the organic group has a defined calciu

Bis-phosphonate compounds

The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a linker group; and Y is a moiety comprising two phosphonate groups. Further aspects of the invention relate to a method for palliative and curative treatment of bone disorders and cancer related disorders, such as breast cancer.